Mechanical cardiac support 2000: Current applications and future trial design

Journal of the American College of Cardiology

Volumn 37, Issue 1, 2001, Pages 340-370

  Stevenson, Lynne Warner ^a   Kormos, Robert L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLOSEQUINAN; HERBACEOUS AGENT; HYDRALAZINE; INOTROPIC AGENT; PROSTACYCLIN; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ARTIFICIAL HEART; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL RESEARCH; CONFERENCE PAPER; DATA BASE; DEVICE; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; GRAFT FAILURE; HEART FAILURE; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MEDICAL ETHICS; OUTPATIENT; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; REGISTER; STUDY; TREATMENT INDICATION;

EQUIPMENT DESIGN; FORECASTING; HEART FAILURE, CONGESTIVE; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS;

EID: 0035173971     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01099-8     Document Type: Conference Paper

References (111)

1. Device Selection
2. Cardiac assist devices
3. Extracorporeal support: Centrifugal pumps
4. Extracorporeal support: The ABIOMED BVS 5000
5. Clinical experience with 111 thoratec ventricular assist devices
6. Improved survival rates support left ventricular assist device implantation early after myocardial infarction
7. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance
8. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device
9. Worldwide experience with the TCI HeartMate system: Issues and future perspective
10. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: A retrospective multi-centre study
11. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation
12. Factors influencing HLA sensitization in implantable LVAD recipients
13. The REMATCH trial: Rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
14. Measurement of health state utilities for economic appraisal
15. Evolving concepts of heart failure: Cooling furnace, malfunctioning pump, enlarging muscle - Part I
16. Evolving concepts of heart failure: Cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart
17. Chronic heart failure management
18. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
19. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study
20. The effect of digoxin on mortality and morbidity in patients with heart failure
21. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure
22. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina
23. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans' Administration Cooperative Study
24. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
25. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
26. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
27. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial
28. Effect of oral milrinone on mortality in severe chronic heart failure
29. Extracorporeal assistance to the circulation and intraaortic balloon pumping
30. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
31. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study
32. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study
33. Cardiomyoplasty-Skeletal Muscle Assist Randomized Trial (C-SMART): Six month results
34. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock
35. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction
36. When is heart failure a surgical disease?
37. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
38. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation
39. APACHE II score and mortality in respiratory failure due to cardiogenic pulmonary edema
40. APACHE II, data accuracy and outcome prediction
41. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
42. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators
43. Cardiogenic shock complicating acute myocardial infarction: Predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries
44. Heart failure patients express strong polarity of preference for either quality of life or survival
45. Outcomes in non-urgent patients awaiting transplantation
46. Left ventricular assist devices as long-term therapy for severe heart failure. Pilot study results demonstrate feasibility of randomized trial
47. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
48. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure
49. Pretransplantation risk factors for death after heart transplantation: A multiinstitutional study. The Transplant Cardiologists Research Database Group
50. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: From CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators
51. Univentricular versus biventricular assist device support
52. Successful biventficular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole
53. Circulatory support for myocardial infarction with ventricular arrhythmias
54. Control of refractory ventricular tachycardia with biventricular assist devices
55. Management of recurrent ventricular tachycardia with ventricular assist device placement
56. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation
57. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database
58. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy
59. Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events
60. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices
61. 100 long-term implantable left ventricular assist devices: The Columbia Presbyterian interim experience
62. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation
63. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion
64. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support
65. Selection criteria for placement of left ventricular assist devices
66. Bethesda Conference: Conference for the design of clinical trials to study circulatory support devices for chronic heart failure
67. Quality of life with an implanted left ventricular assist device
68. Target heart failure populations for newer therapies
69. Measuring quality of life for patients with terminal illness: The Missoula-VITAS quality of life index
70. The last six months of life for patients with congestive heart failure
71. The controlled randomized clinical trial in the evaluation of cancer treatment - The dilemma and alternative trial design
72. Equipoise and the ethics of clinical research
73. Of mice but not men. Problems of the randomized clinical trial
74. Clinical trials - Are they ethical?
75. How to resolve an ethical dilemma concerning randomized clinical trials
76. Outpatient continuous inotropic therapy with end stage heart failure: Palliative or life-prolonging?
77. Ethical factors in the allocation of experimental medical therapies: The chronic left ventricular assist system
78. Understanding controlled trials. What is a patient preference trial?
79. Incorporating patient preferences into randomized trials
80. Patient preferences and randomised clinical trials
81. Are randomized controlled trials controlled? Patient preferences and unblind trials
82. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases
83. Early ambulation after 5 French diagnostic cardiac catheterization: Results of a multicenter trial
84. A comparison of observational studies and randomized, controlled trials
85. Randomized, controlled trials, observational studies, and the hierarchy of research designs
86. Randomized trials or observational tribulations?
87. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
88. Rationale and design of the OPTIME CHF trial: Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure
89. Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal
90. Long-term mechanical circulatory support system reliability recommendation: American Society for Artificial Internal Organs and The Society of Thoracic Surgeons: Long-term mechanical circulatory support system reliability recommendation
91. Development of the Nimbus/Pittsburgh axial flow left ventricular assist system
92. Durability testing of components for the Jarvik 2000 completely implantable axial flow left ventricular assist device
93. Miniature axial flow pump for ventricular assistance in children and small adults
94. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation
95. Left ventricular support with the implantable AB-180 centrifugal pump in sheep with acute myocardial infarction
96. AB-180 circulatory support system: Summary of development and phase I clinical trial
97. Portable pneumatic biventricular driver for the Thoratec ventricular assist device
98. First clinical use of the Thoratec TLC-II portable VAD driver in ambulatory and patient discharge settings
99. A completely implanted left ventricular assist device. Chronic in vivo testing
100. An atrial hydraulic shunt in a total artificial heart. A balance mechanism for the bronchial shunt
101. Steady state hemodynamic and energetic characterization of the Penn State/3M Health Care Total Artificial Heart